---
ver: rpa2
title: 'Position Paper: Integrating Explainability and Uncertainty Estimation in Medical
  AI'
arxiv_id: '2509.18132'
source_url: https://arxiv.org/abs/2509.18132
tags:
- uncertainty
- medical
- clinical
- estimation
- data
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: This position paper addresses the critical gap in medical AI systems
  where existing explainability and uncertainty estimation techniques operate independently,
  failing to provide both interpretable and reliable predictions needed for clinical
  decision-making. The paper proposes Explainable Uncertainty Estimation (XUE), a
  framework that integrates explainability with uncertainty quantification to enhance
  trust and usability in medical AI.
---

# Position Paper: Integrating Explainability and Uncertainty Estimation in Medical AI

## Quick Facts
- arXiv ID: 2509.18132
- Source URL: https://arxiv.org/abs/2509.18132
- Authors: Xiuyi Fan
- Reference count: 40
- Key outcome: Proposes XUE (Explainable Uncertainty Estimation) framework integrating explainability with uncertainty quantification for trustworthy medical AI systems

## Executive Summary
This position paper identifies a critical gap in medical AI where existing explainability and uncertainty estimation techniques operate independently, failing to provide both interpretable and reliable predictions needed for clinical decision-making. The paper proposes Explainable Uncertainty Estimation (XUE) as a unified framework that combines uncertainty quantification with explainable AI to enhance trust and usability in medical AI systems. By systematically mapping medical uncertainty concepts to AI uncertainty categories and identifying key challenges across multimodal data, communication, evaluation, domain knowledge integration, and generative models, the authors establish guiding principles for developing robust XUE systems that address the dual needs of reliability and interpretability in clinical settings.

## Method Summary
The paper presents a conceptual framework for Explainable Uncertainty Estimation (XUE) that integrates uncertainty quantification techniques with explainable AI methods for medical applications. The approach involves decomposing medical uncertainty into aleatoric (data noise), epistemic (model knowledge gaps), and distributional (novel populations) components, then applying modality-specific quantification techniques (Bayesian NNs for tabular data, MC Dropout for imaging, probabilistic RNNs for time series) while maintaining traceability to data quality and model factors. The framework proposes combining feature-based explanations (saliency maps, SHAP), concept-based explanations (TCAV), and example-based explanations (prototypes, counterfactuals) with uncertainty estimates, ultimately delivering multi-format communication outputs (numerical scores, visual overlays, linguistic probability statements) tailored to clinical user roles.

## Key Results
- Identifies that uncertainty estimation alone is insufficient for clinical adoption without interpretable explanations
- Systematically maps medical uncertainty sources to AI uncertainty categories (aleatoric, epistemic, distributional)
- Proposes five key challenges for XUE implementation: multimodal uncertainty quantification, effective clinician communication, evaluation frameworks, domain knowledge integration, and uncertainty in generative models
- Establishes guiding principles for robust XUE development emphasizing modality-specific approaches and traceability

## Why This Works (Mechanism)

### Mechanism 1
- Claim: Separating uncertainty types (aleatoric, epistemic, distributional) enables targeted explanations that align with clinical reasoning.
- Mechanism: Map medical uncertainty sources to AI uncertainty categories—aleatory (data noise/biological variability) to inherent noise, epistemic (knowledge gaps) to model uncertainty, distributional (novel populations) to out-of-distribution detection—then apply modality-appropriate quantification techniques for each.
- Core assumption: Clinicians can act more appropriately when they understand whether uncertainty stems from data quality issues versus model limitations versus unfamiliar patient presentations.
- Evidence anchors:
  - [abstract] "We systematically map medical uncertainty to AI uncertainty concepts and identify key challenges in implementing XUE."
  - [section III.B.1] "The three primary sources of uncertainty in medicine align with corresponding AI uncertainty categories... These uncertainties manifest differently depending on the type of data being analyzed."
  - [corpus] Related paper "All You Need for Counterfactual Explainability Is Principled and Reliable Estimate of Aleatoric and Epistemic Uncertainty" supports the position that uncertainty decomposition is foundational for explainability, though empirical validation in clinical settings remains limited.
- Break condition: If uncertainty decomposition adds cognitive burden without improving clinical decisions, the mechanism fails—requires user validation.

### Mechanism 2
- Claim: Traceable uncertainty explanations—linking confidence scores to specific data quality issues or model limitations—improve clinical trust and enable targeted interventions.
- Mechanism: Rather than presenting a single aggregate uncertainty score, systems should provide multi-level representations (confidence intervals, uncertainty overlays, verbal probability statements) that trace back to source factors (missing EHR values, imaging artifacts, sensor drift, distribution shift).
- Core assumption: Clinicians will make better decisions when they can identify uncertainty origins and take corrective actions (order additional tests, seek specialist consultation).
- Evidence anchors:
  - [abstract] "Uncertainty estimation alone is insufficient without explainability, and vice versa, as medical practitioners require both confidence measures and intuitive explanations to make informed decisions under uncertainty."
  - [section IV, Challenge 2] "This static representation fails to capture how uncertainty evolves throughout the model's reasoning process, making it difficult for clinicians to assess the source of uncertainty."
  - [section V, Principle 2] "Uncertainty scores should be linked to data quality issues, ensuring that uncertainty is not just reported but understood in context."
  - [corpus] "Shades of Uncertainty" study examines how visualization affects trust, suggesting communication modality matters but not establishing optimal formats.
- Break condition: If traceability information is ignored or misinterpreted by clinicians in time-pressured settings, the added complexity provides no benefit.

### Mechanism 3
- Claim: Post-hoc uncertainty estimation methods applied to pre-trained models offer a practical deployment path without requiring full model retraining.
- Mechanism: Use auxiliary uncertainty estimators (BayesCap for Bayesian calibration, Dirichlet meta-models for evidential uncertainty, reconstruction-error-based distributional uncertainty) on frozen models to retrofit uncertainty quantification to existing deployed systems.
- Core assumption: Clinical AI systems already in use can be enhanced incrementally rather than requiring complete architectural replacement.
- Evidence anchors:
  - [section II.B.1] "Post-hoc approaches such as BayesCap mitigate these drawbacks by applying a Bayesian identity mapping to a pre-trained deterministic model."
  - [section II.B.3] "[43] propose a post-hoc Dirichlet meta-model that leverages pre-trained neural architectures to quantify uncertainty without requiring additional data."
  - [section II.B.4] "[47, 48, 49] leverage the reconstruction error—i.e., the distance to the training set—to quantify uncertainty... aim to minimize additional computational overhead."
  - [corpus] Weak direct evidence—corpus papers focus on new architectures rather than retrofitting existing systems. Validation of post-hoc calibration quality on clinical data remains underexplored.
- Break condition: If post-hoc methods produce poorly calibrated uncertainty estimates on clinical out-of-distribution cases, they may create false confidence and should not be deployed.

## Foundational Learning

- Concept: **Aleatoric vs. Epistemic vs. Distributional Uncertainty**
  - Why needed here: The entire XUE framework hinges on correctly identifying uncertainty sources to map them to appropriate AI techniques and clinical explanations. Without this distinction, uncertainty communication becomes a single opaque number.
  - Quick check question: A model trained on adult chest X-rays receives a pediatric scan. Is this aleatoric, epistemic, or distributional uncertainty?

- Concept: **Post-hoc vs. Intrinsic Uncertainty Estimation**
  - Why needed here: Deployment strategy depends on whether you can retrain models from scratch (BNNs, ensembles) or must retrofit uncertainty to frozen models (BayesCap, Dirichlet meta-models). Clinical constraints often favor the latter.
  - Quick check question: Your hospital has a deployed diabetic retinopathy classifier that clinicians trust but which lacks uncertainty output. Which approach family should you investigate first?

- Concept: **Medical Uncertainty Taxonomy (Han et al.)**
  - Why needed here: Mapping clinical uncertainty language (diagnostic, prognostic, treatment uncertainty) to AI outputs requires understanding the three dimensions: source, issue, and locus. This determines communication strategies for different stakeholders.
  - Quick check question: A surgeon wants to know if the model's uncertainty comes from missing patient history or from genuinely ambiguous imaging findings. Which dimension of Han's taxonomy does this question address?

## Architecture Onboarding

- Component map:
  - Uncertainty Decomposition Layer: Modality-specific modules (Bayesian NNs for tabular/EHR, MC Dropout for imaging, probabilistic RNNs for time series) that separate aleatoric, epistemic, and distributional components
  - Explanation Generation Layer: Feature-based (saliency maps, SHAP), concept-based (TCAV), or example-based (prototypes, counterfactuals) explanations augmented to indicate confidence per feature/concept
  - Traceability Engine: Links uncertainty scores to source factors (data quality flags, training set coverage metrics, distribution shift detectors)
  - Communication Interface: Model-agnostic visualization tools offering multi-format output (numerical, visual overlays, linguistic) tailored to user role (clinician vs. patient)

- Critical path:
  1. Identify dominant uncertainty type(s) for your clinical application (diagnostic imaging → focus on aleatoric + distributional; prognosis from EHR → focus on epistemic)
  2. Select modality-appropriate uncertainty quantification technique (consider post-hoc if model exists, intrinsic if greenfield)
  3. Implement traceability linking uncertainty to data/model factors
  4. Design communication format through clinician iterative feedback

- Design tradeoffs:
  - **Accuracy vs. interpretability**: Complex BNNs provide richer uncertainty but are harder to explain than entropy-based auxiliary methods
  - **Computational cost vs. deployment feasibility**: Ensembles and MC Dropout require multiple forward passes; post-hoc Dirichlet methods add minimal inference overhead but may sacrifice calibration quality
  - **Comprehensiveness vs. cognitive load**: Full traceability with all uncertainty sources vs. simplified single-score display for time-pressed clinicians

- Failure signatures:
  - **False confidence**: Well-calibrated on validation data but overconfident on clinical edge cases (distribution shift undetected)
  - **Explanation-uncertainty mismatch**: High uncertainty in regions where explanation highlights strong features, or vice versa—indicates decoupled XAI and UE pipelines
  - **Ignored outputs**: Clinicians consistently disregard uncertainty displays, suggesting format misalignment with workflow or cognitive overload
  - **Cascading errors**: Uncertainty in one modality (missing EHR values) propagates incorrectly through multimodal fusion without appropriate attenuation

- First 3 experiments:
  1. **Baseline calibration audit**: Take your existing deployed model, apply a post-hoc uncertainty estimator (e.g., BayesCap or Dirichlet meta-model), and evaluate calibration (ECE, Brier scores) on held-out clinical data including known edge cases. Establish whether uncertainty estimates are trustworthy before adding explanation layers.
  2. **Traceability user study**: Present clinicians with uncertainty estimates that have three levels of traceability (score only, score + source category, score + source + actionable suggestion). Measure decision quality and confidence alignment across conditions with a small cohort (n=5-10).
  3. **Cross-modality consistency check**: If your system uses multiple data types (e.g., imaging + EHR), verify that uncertainty from one modality appropriately influences overall prediction confidence. Test with artificially degraded inputs (missing EHR fields, noised images) to confirm uncertainty decomposition behaves as expected.

## Open Questions the Paper Calls Out

### Open Question 1
- Question: How can aleatoric, epistemic, and distributional uncertainty be consistently quantified and disentangled across heterogeneous medical data modalities (EHRs, imaging, time series)?
- Basis in paper: [explicit] Challenge 1 states "Ensuring consistency and interpretability across these modalities remains a fundamental challenge" and proposes separating uncertainty types for each modality as solution ideas.
- Why unresolved: Different modalities require distinct technical approaches (Bayesian NNs for tabular, MC dropout for imaging, probabilistic RNNs for time series), but no unified framework exists.
- What evidence would resolve it: A cross-modal benchmark showing consistent uncertainty decomposition across EHR, imaging, and time series tasks on shared patient cohorts.

### Open Question 2
- Question: What evaluation metrics and benchmarks can assess both the numerical fidelity and clinical interpretability of XUE systems?
- Basis in paper: [explicit] Challenge 3 notes "there is no established framework for evaluating the quality of explanations alongside uncertainty estimates" and ECE/Brier scores fail to capture clinical usability.
- Why unresolved: Quantitative metrics (calibration, stability) and qualitative feedback (clinician interpretability) have not been integrated into standardized benchmarks.
- What evidence would resolve it: A validated evaluation protocol combining uncertainty calibration metrics with structured clinician usability assessments across diverse medical datasets.

### Open Question 3
- Question: How can domain knowledge from clinical guidelines be systematically integrated into data-driven uncertainty estimation to improve handling of rare conditions and evolving medical knowledge?
- Basis in paper: [explicit] Challenge 4 states purely data-driven approaches "remain inherently limited by the quality, completeness, and representativeness" of training data, especially for atypical presentations.
- Why unresolved: Proposed solutions (LLM knowledge extraction, hybrid probabilistic models, dynamic updating) lack validated implementations demonstrating improved uncertainty for rare cases.
- What evidence would resolve it: Comparative studies showing reduced uncertainty calibration error on rare conditions when domain knowledge is integrated versus data-only baselines.

### Open Question 4
- Question: How can uncertainty be reliably quantified and communicated in medical LLM outputs given their free-text format and susceptibility to hallucinations?
- Basis in paper: [explicit] Challenge 5 identifies LLMs introduce unique challenges including "inherent stochasticity, reliance on pretrained knowledge, and susceptibility to hallucinations" with unclear uncertainty indicators.
- Why unresolved: Proposed approaches (confidence-weighted generation, RAG, interactive exploration) remain largely conceptual without clinical validation.
- What evidence would resolve it: Clinical user studies demonstrating that uncertainty-highlighting interfaces reduce clinician overreliance on incorrect LLM-generated recommendations.

## Limitations
- No empirical validation of proposed XUE framework mechanisms
- Integration methodology between explainability and uncertainty quantification is underspecified
- Communication strategies lack empirical grounding for different clinical contexts
- No validation of post-hoc uncertainty estimation quality on clinical out-of-distribution data

## Confidence
- **High**: The need for integrated explainability and uncertainty estimation in medical AI is well-established
- **Medium**: The mapping between medical and AI uncertainty types is conceptually sound
- **Low**: Proposed communication formats and evaluation frameworks lack empirical validation

## Next Checks
1. **Calibration Validation**: Apply post-hoc uncertainty estimation (e.g., Dirichlet meta-models) to existing clinical AI systems and evaluate calibration performance on known challenging cases (distribution shift, data quality issues)
2. **User Comprehension Study**: Test whether clinicians can correctly identify uncertainty sources from multi-level traceability displays across different medical specialties and experience levels
3. **Clinical Decision Impact**: Measure whether XUE-enhanced systems lead to better clinical decisions (reduced false positives, appropriate follow-up actions) compared to baseline systems with uncertainty or explainability alone